公司概覽
業務類別 Medical Devices
業務概覽 Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives roughly 60% of sales outside the United States.
公司地址 100 Abbott Park Road, Abbott Park, IL, USA, 60064-6400
電話號碼 +1 224 667-6100
傳真號碼 --
公司網頁 https://www.abbott.com
員工數量 115000
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Mr. Robert B. Ford Chairman of the Board and Chief Executive Officer 美元 1.50M 20/02/2026
Mr. Daniel Gesua Sive Salvadori Executive Vice President and Group President, Established Pharmaceuticals and Nutritional Products 美元 879.27K 20/02/2026
Mr. Eric Shroff Senior Vice President, Rapid and Molecular Diagnostics -- 20/02/2026
Mr. Christopher J. Scoggins Executive Vice President, Diabetes Care -- 20/02/2026
Ms. Mary K. Moreland Executive Vice President, Human Resources -- 20/02/2026
Ms. Lisa D. Earnhardt Executive Vice President and Group President, Medical Devices 美元 879.27K 20/02/2026
Mr. Philip P. Boudreau Executive Vice President, Finance and Chief Financial Officer 美元 884.04K 20/02/2026
Mr. Louis H. Morrone Executive Vice President, Core Diagnostics -- 20/02/2026
Ms. Elizabeth C. Cushman Executive Vice President, General Counsel and Secretary -- 20/02/2026
Mr. John A. Mccoy, Jr Vice President, Finance, Controller and Principal Accounting Officer -- 20/02/2026
 
董事會成員
董事會 職務 更新日期
Dr. Robert J. Alpern,M.D. Independent Director 20/02/2026
Mr. John G. Stratton Independent Director 20/02/2026
Ms. Nancy Mckinstry Lead Independent Director 20/02/2026
Dr. Sally E. Blount, PhD Independent Director 20/02/2026
Mr. Michael F. Roman Independent Director 20/02/2026
Mr. Robert B. Ford Chairman of the Board and Chief Executive Officer 20/02/2026
Mr. Daniel J. Starks Independent Director 20/02/2026
General Darren W. McDew, U.S.A.F. (Ret.) Independent Director 20/02/2026
Ms. Patricia P. Gonzalez Independent Director 20/02/2026
Ms. Michelle A. Kumbier Independent Director 20/02/2026
Mr. Michael G. O’Grady Independent Director 20/02/2026
Ms. Claire Babineaux-Fontenot Independent Director 20/02/2026
Ms. Nita Ahuja, M.D. Director 20/02/2026
 
所屬ETF (更新日期: 07/03/2026 04:44)
代號 名稱 佔比% 持有日期
CHGXStance Sustainable Beta ETF0.001%27/02/2026
GINNGoldman Sachs Innovate Equity ETF0.001%27/02/2026
CRTCXtrackers US National Crtcl Techs ETF0.001%26/02/2026
JPUSJPMorgan Diversified Return US Eq ETF0.001%27/02/2026
RAFEPIMCO RAFI ESG US ETF0.001%26/02/2026
CFAVictoryShares US 500 Volatility Wtd ETF0.001%27/02/2026
USNZXtrackers Net Zero Pwy Par Alg US Eq ETF0.001%26/02/2026
PBPInvesco S&P 500 BuyWrite ETF0.001%27/02/2026
OALCOneAscent Large Cap Core ETF0.001%27/02/2026
EVUSiShares ESG Aware MSCI USA Value ETF0.001%28/02/2026
LEADSiren DIVCON Leaders Dividend ETF0.001%27/02/2026
TALVTransamerica Large Value Active ETF0.001%26/02/2026
QWLDState Street® SPDR® MSCI Wld StrtFcs ETF0.001%27/02/2026
AVTMAvantis Total Equity Markets ETF0.0005%28/02/2026
FEUSFlexShares ESG & Clmt US Lrg Cap Cr Idx0.0005%27/02/2026
CRBNiShares Low Carbon Optd MSCI ACWI ETF0.0005%28/02/2026
DURAVanEck Durable High Dividend ETF0.0005%28/02/2026
VSLUApplied Finance Valuation LgCp ETF0.0005%27/02/2026
CFOVictoryShares US 500 Enh Vol Wtd ETF0.0005%27/02/2026
RSPAInvesco S&P 500 Eq Wght Inc Adv ETF0.0004%27/02/2026
  1    2    3    4    5    6    7    8    9    10   11    12    13    14    15    16    17    18    19    20    21  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.